Oncodesign, experts in precision medicine

Home . About us

Our mission

“To discover new innovative therapies that are effective against cancers and serious diseases with no known treatments.”

Find out more about our mission and vision

Oncodesign expert in precision medicine thanks to our innovative technologies

To identify the path to innovation, in harmony with life

Life is constantly adapting to new conditions. It innovates to keep going. We put our intelligence at your service to guide you towards success. Oncodesign’s culture is based on sharing, mutual assistance, community, sociability and, more generally, solidarity.

Get to know our values

Key figures

1995

year created

230

employees incl. 22% PhD

3

sites

1,000

clients

€36.2 Millions

revenue (2021)

€11.5 Millions

R&D investment

4

partnerships

2

internal programs

market capitalization

Complementary expertise to discover and develop your molecules

Discover our innovation model

Optimize your molecule with Oncodesign Service, a continuum of services in drug discovery

A range of services

Optimize molecule development

Our Biotech programs

Become a partner

Artificial Intelligence

Speed up drug research

Homing program

An alliance to make your drug development in oncology a success

Working in precision medicine since 1995

Philippe Genne, Founder and CEO of Oncodesign

1995

Creation

Creation by its CEO and founder Philippe Genne, in Dijon, as a pharmacology services company to select the best oncology drug candidates.

2005

Pharmimage

Foundation by Oncodesign of a regional center of excellence in pharmaco-imaging to monitor the effect of therapies and identify translational efficacy biomarkers for precision medicine. Pharmimage brings together hospitals, biotechnology and pharmaceutical companies in Dijon, France.

Discover all